Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants

被引:14
|
作者
Madewell, Zachary J. [1 ]
Yang, Yang [2 ]
Longini, Ira M., Jr. [1 ]
Halloran, M. Elizabeth [3 ,4 ]
Vespignani, Alessandro [5 ]
Dean, Natalie E. [6 ]
机构
[1] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA
[2] Univ Georgia, Dept Stat, Athens, GA USA
[3] Univ Washington, Dept Biostat, Seattle, WA USA
[4] Fred Hutchinson Canc Ctr, Seattle, WA USA
[5] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA USA
[6] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA
基金
美国国家卫生研究院;
关键词
Serial interval; Generation time; COVID-19; Symptom onset; Generation interval; Incubation period; TRANSMISSION DYNAMICS; COVID-19; CORONAVIRUS; OUTBREAK; PROVINCE; CHINA;
D O I
10.1186/s12879-023-08407-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The serial interval is the period of time between symptom onset in the primary case and symptom onset in the secondary case. Understanding the serial interval is important for determining transmission dynamics of infectious diseases like COVID-19, including the reproduction number and secondary attack rates, which could influence control measures. Early meta-analyses of COVID-19 reported serial intervals of 5.2 days (95% CI: 4.9-5.5) for the original wild-type variant and 5.2 days (95% CI: 4.87-5.47) for Alpha variant. The serial interval has been shown to decrease over the course of an epidemic for other respiratory diseases, which may be due to accumulating viral mutations and implementation of more effective nonpharmaceutical interventions. We therefore aggregated the literature to estimate serial intervals for Delta and Omicron variants. Methods This study followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A systematic literature search was conducted of PubMed, Scopus, Cochrane Library, ScienceDirect, and preprint server medRxiv for articles published from April 4, 2021, through May 23, 2023. Search terms were: ("serial interval" or "generation time"), ("Omicron" or "Delta"), and ("SARS-CoV-2" or "COVID-19"). Meta-analyses were done for Delta and Omicron variants using a restricted maximum-likelihood estimator model with a random effect for each study. Pooled average estimates and 95% confidence intervals (95% CI) are reported. Results There were 46,648 primary/secondary case pairs included for the meta-analysis of Delta and 18,324 for Omicron. Mean serial interval for included studies ranged from 2.3-5.8 days for Delta and 2.1-4.8 days for Omicron. The pooled mean serial interval for Delta was 3.9 days (95% CI: 3.4-4.3) (20 studies) and Omicron was 3.2 days (95% CI: 2.9-3.5) (20 studies). Mean estimated serial interval for BA.1 was 3.3 days (95% CI: 2.8-3.7) (11 studies), BA.2 was 2.9 days (95% CI: 2.7-3.1) (six studies), and BA.5 was 2.3 days (95% CI: 1.6-3.1) (three studies). Conclusions Serial interval estimates for Delta and Omicron were shorter than ancestral SARS-CoV-2 variants. More recent Omicron subvariants had even shorter serial intervals suggesting serial intervals may be shortening over time. This suggests more rapid transmission from one generation of cases to the next, consistent with the observed faster growth dynamic of these variants compared to their ancestors. Additional changes to the serial interval may occur as SARS-CoV-2 continues to circulate and evolve. Changes to population immunity (due to infection and/or vaccination) may further modify it.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature
    Pottage, Thomas
    Onianwa, Okechukwu
    Atkinson, Barry
    Spencer, Antony
    Bennett, Allan M.
    VIROLOGY, 2023, 583 : 27 - 28
  • [32] A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
    Hanjun Zhao
    Kelvin Kai-Wang To
    Hoiyan Lam
    Chuyuan Zhang
    Zheng Peng
    Xinjie Meng
    Xiankun Wang
    Anna Jinxia Zhang
    Bingpeng Yan
    Jianpiao Cai
    Man Lung Yeung
    Jasper Fuk-Woo Chan
    Kwok-Yung Yuen
    Cell Discovery, 8
  • [33] The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
    Chavda, Vivek P.
    Bezbaruah, Rajashri
    Deka, Kangkan
    Nongrang, Lawandashisha
    Kalita, Tutumoni
    VACCINES, 2022, 10 (11)
  • [34] COVID-19 severity from Omicron and Delta SARS-CoV-2 variants
    Wrenn, Jesse O.
    Pakala, Suman B.
    Vestal, Grant
    Shilts, Meghan H.
    Brown, Hunter M.
    Bowen, Sara M.
    Strickland, Britton A.
    Williams, Timothy
    Mallal, Simon A.
    Jones, Ian D.
    Schmitz, Jonathan E.
    Self, Wesley H.
    Das, Suman R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 832 - 836
  • [35] Understanding the mechanisms of increased pathogenicity and virulence of SARS-CoV-2 Delta and Omicron variants
    Dutta, Mandira
    Voth, Gregory A.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 136A - 136A
  • [36] Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
    Kim, A. Reum
    Lee, Jiyoung
    Park, Somi
    Kang, Sung Woon
    Lee, Yun Woo
    Lim, So Yun
    Chang, Euijin
    Bae, Seongman
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Kim, Sung-Han
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (01) : 133 - 135
  • [37] Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
    Gudmundur L. Norddahl
    Pall Melsted
    Kristbjorg Gunnarsdottir
    Gisli H. Halldorsson
    Thorunn A. Olafsdottir
    Arnaldur Gylfason
    Mar Kristjansson
    Olafur T. Magnusson
    Patrick Sulem
    Daniel F. Gudbjartsson
    Unnur Thorsteinsdottir
    Ingileif Jonsdottir
    Kari Stefansson
    Nature Communications, 13
  • [38] Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
    Tseng, Hung Fu
    Ackerson, Bradley K.
    Luo, Yi
    Sy, Lina S.
    Talarico, Carla A.
    Tian, Yun
    Bruxvoort, Katia J.
    Tubert, Julia E.
    Florea, Ana
    Ku, Jennifer H.
    Lee, Gina S.
    Choi, Soon Kyu
    Takhar, Harpreet S.
    Aragones, Michael
    Qian, Lei
    NATURE MEDICINE, 2022, 28 (05) : 1063 - +
  • [39] Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
    Antonelli, Michela
    Pujol, Joan Capdevila
    Spector, Tim D.
    Ourselin, Sebastien
    Steves, Claire J.
    LANCET, 2022, 399 (10343): : 2263 - 2264
  • [40] SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
    Keyel, Alexander C.
    Russell, Alexis
    Plitnick, Jonathan
    V. Rowlands, Jemma
    Lamson, Daryl M.
    Rosenberg, Eli
    George, Kirsten St.
    EMERGING INFECTIOUS DISEASES, 2022, 28 (10) : 1990 - 1998